ADAR and neoplasm: Consequently, loss of ADAR1 results in the induction of IFN, a key anti-tumour cytokine, and subsequently to robust inflammation of the tumor microenvironment (substantial tumor infiltration by CD8+T cells) and increased response to tumor restriction by checkpoint inhibitors.27